MSU Foundation will manage the sector-agnostic vehicle, which will invest $100,000 to $250,000 in pre-seed rounds for Michigan-based businesses.

Cancer therapy developer Oric, whose backers include Memorial Sloan, Taiho and Hartford HealthCare, floated at the top of its range in an expanded IPO.

The digital life insurer has revealed it closed a series B round in February that included Sammons Financial to increase its total funding to more than $67m.

GV led a series B round for Digits that was disclosed as it publicly launched its business expenditure analysis software, four months after its series A.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The payment automation software producer received another $128m for a Mastercard-backed round that lifted its overall funding past $1.1bn.

GV, AbbVie Ventures and NS Investment have contributed to a series B round for the oncology drug developer, which has now raised a total of $103m.

The HLB-led group owns nearly half of vaccine product developer Immunomic Therapeutics following a $61.3m commitment this year.

Partners Innovation Fund joined Syncona to provide $20m for the neurological disease drug developer's series A round, which is sized at up to $77m.